| J1602 | Injection, golimumab, 1 mg, for intravenous use | 87,380 | $10 | $873.8K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 122,800 | $1 | $491.2K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 12,200 | $30 | $402.6K |
| J3262 | Injection, tocilizumab, 1 mg | 44,800 | $10 | $224K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 5,160 | $30 | $134.2K |
| J0897 | Injection, denosumab, 1 mg | 6,120 | $20 | $110.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,210 | $90 | $104.1K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 620 | $50 | $27.7K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 510 | $50 | $26.6K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 270 | $90 | $24.1K |